GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » InnovaQor Inc (OTCPK:INQR) » Definitions » Earnings per Share (Diluted)

InnovaQor (InnovaQor) Earnings per Share (Diluted) : $-0.01 (TTM As of Sep. 2023)


View and export this data going back to . Start your Free Trial

What is InnovaQor Earnings per Share (Diluted)?

InnovaQor's Earnings per Share (Diluted) for the three months ended in Sep. 2023 was $-0.00. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2023 was $-0.01.

InnovaQor's EPS (Basic) for the three months ended in Sep. 2023 was $-0.00. Its EPS (Basic) for the trailing twelve months (TTM) ended in Sep. 2023 was $-0.01.

InnovaQor's EPS without NRI for the three months ended in Sep. 2023 was $-0.00. Its EPS without NRI for the trailing twelve months (TTM) ended in Sep. 2023 was $-0.01.


InnovaQor Earnings per Share (Diluted) Historical Data

The historical data trend for InnovaQor's Earnings per Share (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

InnovaQor Earnings per Share (Diluted) Chart

InnovaQor Annual Data
Trend Jun02 Jun03 Jun04 Jun05 Jun06 Jun07 Dec21 Dec22
Earnings per Share (Diluted)
Get a 7-Day Free Trial -0.15 -0.16 -0.31 - -0.01

InnovaQor Quarterly Data
Sep05 Dec05 Mar06 Jun06 Sep06 Dec06 Mar07 Jun07 Sep07 Dec07 Mar08 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Earnings per Share (Diluted) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - -0.01 - - -

Competitive Comparison of InnovaQor's Earnings per Share (Diluted)

For the Health Information Services subindustry, InnovaQor's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


InnovaQor's PE Ratio Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, InnovaQor's PE Ratio distribution charts can be found below:

* The bar in red indicates where InnovaQor's PE Ratio falls into.



InnovaQor Earnings per Share (Diluted) Calculation

Earnings Per Share (EPS) is the amount of earnings per outstanding share of the company's stock. In calculating earnings per share, the dividends of preferred stocks need to subtracted from the total net income first.

InnovaQor's Earnings Per Share (Diluted) for the fiscal year that ended in Dec. 2022 is calculated as

Diluted Earnings Per Share (A: Dec. 2022 ) = (Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(-1.614-0)/236.258
=-0.01

InnovaQor's Earnings Per Share (Diluted) for the quarter that ended in Sep. 2023 is calculated as

Diluted Earnings Per Share (Q: Sep. 2023 )=(Net Income - Preferred Dividends / Shares Outstanding (Diluted Average)
=(-0.339-0)/244.953
=-0.00

Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.01

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Companies also reported diluted shares in their financial reports. Diluted shares include the shares of convertibles or warrants outstanding.


InnovaQor  (OTCPK:INQR) Earnings per Share (Diluted) Explanation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


InnovaQor Earnings per Share (Diluted) Related Terms

Thank you for viewing the detailed overview of InnovaQor's Earnings per Share (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.


InnovaQor (InnovaQor) Business Description

Traded in Other Exchanges
N/A
Address
400 S. Australian Avenue, Suite 800, West Palm Beach, FL, USA, 33401
InnovaQor Inc provides information technology solutions and services to healthcare and laboratory customers in the United States. Its goal is to develop and deliver a technology-based medical professional's network communication platform to a broad range of healthcare professionals and businesses using a subscription revenue model with added value bolt-on services.
Executives
Francisco Iii Roca director 400 SOUTH AUSTRALIAN AVENUE, 8TH FLOOR, WEST PALM BEACH FL 33401
Darrell L Peterson director, officer: Chief Executive Officer 2390 CIRCLE DRIVE, WEST PALM BEACH FL 33406
Sharon Lynne Hollis director 400 SOUTH AUSTRALIAN AVENUE, 8TH FLOOR, WEST PALM BEACH FL 33401
Justin Doherty director 400 S. AUSTRALIAN AVENUE, SUITE 800, WEST PALM BEACH FL 33401
Thomas Joseph Bellante officer: Chief Financial Officer 14706 CROYDON PLACE, TAMPA FL 33618
Jayne Kirby officer: VP Finance 1035 LAURIER O., SUITE 200, MONTREAL A8 H2V 2L1
Arthur Gelston 10 percent owner 1035 LAURIER STREET WEST, MONTREAL A8 H2V 2L1
Visual Healthcare Corp 10 percent owner 790 ROCKLAND AVE., MONTREAL, QC. A8 H2V 2Z6
Philippe Rainville officer: CFO 391A LAURIER WEST, MONTREAL A8 H2V 2K3
Philippe Panzini director 391A LAURIER WEST, MONTREAL A8 H2V 2K3
Michel Maksud officer: VP Technology 391A LAURIER WEST, MONTREAL A8 H2V 2K3
Gerard Dab director, officer: CEO and Chairman of the Board 391A LAURIER WEST, MONTREAL A8 H2V 2K3
Louis J Lombardo director 108 SMITH LAKE ROAD, ROSCOE NY 12776
Visualmed Clinical Systems Corp 10 percent owner
Barry Scharf officer: VP Operations 391A LAURIER WEST, MONTREAL A8 H2V 2K3